Phase Iii - Epidemiology

Relevant Publications

[Pharmacological properties and clinical development overview of pertuzumab (genetical recombination), trastuzumab (genetical recombination) and vorhyaluronidase alfa (genetical recombination) (PHESGO combination for ‍subcutaneous injection MA, IN)].

Issue Release: 2024

Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)-A randomized, placebo-controlled phase II feasibility/pilot study.

Issue Release: 2024

Effectiveness of Group Health Education on \"Perceived Stress\" among High-School Children of Kolar: A Cluster Randomized Controlled Trial.

Issue Release: 2024

Letter to the editor \"risk prediction model for cisplatin-induced acute kidney injury in patients with head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III JCOG1008 trial \".

Issue Release: 2024

Final analysis of a phase II trial of neoadjuvant chemoimmunotherapy for locoregionally advanced head and neck squamous cell carcinoma.

Issue Release: 2024

Influence of Di--butyl Phosphoric Acid on Cerium Redox and Speciation in Tri--butyl Phosphate.

Issue Release: 2024

Futility Interim Analysis Based on Probability of Success Using a Surrogate Endpoint.

Issue Release: 2024

A single-center, assessor-blinded, randomized controlled clinical trial to test the safety and efficacy of a novel brain-computer interface controlled functional electrical stimulation (BCI-FES) intervention for gait rehabilitation in the chronic stroke population.

Issue Release: 2024

Immunotherapy for hepatocellular carcinoma: the next evolution in expanding access to liver transplantation.

Issue Release: 2024

Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literature.

Issue Release: 2024

Comparison of the efficacy, safety, and tolerability of the new FDC telmisartan + bisoprolol with comparator telmisartan + metoprolol succinate ER combination therapy for stage 1 and stage 2 hypertension: The double-blind, multicentric, phase-III clinical study.

Issue Release: 2024

Does metformin prolong pregnancy in preterm pre-eclampsia? A study protocol for a South African, hospital-based double-blind, randomised, placebo-controlled trial.

Issue Release: 2024

Living donor liver transplantation for patients with portal vein thrombosis: high-volume single center experience.

Issue Release: 2024

Neoadjuvant and Adjuvant Treatment for Early-Stage Resectable Non-small Cell Lung Cancer (NSCLC): Consensus Recommendations from the International Association for the Study of Lung Cancer (IASLC).

Issue Release: 2024

Efficacy and Safety of Ganyushu Granule in Treatment of Premenstrual Syndrome with Gan (Liver) Depression and Qi Stagnation Syndrome: A Randomized, Double-Blind, Multi-Center, Phase-II Clinical Trial.

Issue Release: 2024

Immune checkpoint inhibitor combinations for patients with advanced endometrial cancer: a network meta-analysis and cost-utility analysis.

Issue Release: 2024

Prognostic value of lymphocytes in patients with breast cancer receiving radiotherapy after breast-conserving surgery: A post hoc analysis of a phase III randomized trial.

Issue Release: 2024

Breast cancer epigenetics: current and evolving treatment.

Issue Release: 2024

Longitudinal neurofunctional changes in medication overuse headache patients after mindfulness practice in a randomized controlled trial (the MIND-CM study).

Issue Release: 2024

Vibrational analyses of the reaction of oxymyoglobin with NO using a photolabile caged NO donor at cryogenic temperatures.

Issue Release: 2024

What Are Some Examples of Incorrect Risk Assessments?

What Are Some Challenges in Identifying Drug Targets?

How Does Respite Care Impact Public Health?

How Can Countries and Organizations Get Involved with GOARN?

What Are the Challenges in Controlling Culex Mosquitoes?

What is Socioeconomic Status?

How Are Blockchain Technologies Being Utilized?

What Strategies Can Mitigate the Impact of Limited Healthcare Capacity?

How does access to healthcare services affect epidemiological outcomes?

What Are Psychological Impacts in Epidemiology?

Phase Iii - Epidemiology

Relevant Publications

Partnered Content Networks

Relevant Topics